Find Federal Grants
Research Grants to Inform Firearm-Related Violence and Injury Prevention Strategies (R01)
Centers for Disease Control and Prevention - ERA · RFA-CE-23-005
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
National Institutes of Health · PAR-23-058
NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds (K26 - Independent Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-22-012
Research Grants to Rigorously Evaluate Innovative and Promising Strategies to Prevent Firearm-Related Violence and Injuries (R01)
Centers for Disease Control and Prevention - ERA · RFA-CE-23-006
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional)
National Institutes of Health · RFA-OD-23-005
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-007
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-006
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-011
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-010
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-002
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-005
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-004
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-23-003
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
National Institutes of Health · RFA-CA-23-008
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-23-009
Centers for Disease Control and Prevention - ERA · RFA-GH-23-003
Rural Utilities Service · RUS-23-01-DLT
National Institutes of Health · PAR-23-057
NIDDK Information Network Coordinating Unit: dkNET-CU (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-22-017
U.S. Mission to Zimbabwe · 005-2022